We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
16 hedge funds and large institutions have $704K invested in Interpace Biosciences, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
14% more funds holding
Funds holding: 14 → 16 (+2)
28% less capital invested
Capital invested by funds: $984K → $704K (-$280K)
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$288K |
| 2 |
Morgan Stanley
New York
|
+$141K |
| 3 |
AS
Arxis Securities
New York
|
+$130K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 5 |
JP Morgan Chase
New York
|
+$50.6K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$292K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$108K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$64K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.72K |